Novacyt: IVDR accreditation for Yourgene DPYD test
The clinical diagnostics company states that this genotyping test 'enables the identification of cancer patients at risk of suffering a severe, and potentially life-threatening, reaction to common chemotherapy'.
The Yourgene DPYD test is used to identify patients with dihydropyrimidine dehydrogenase (DPD) enzyme deficiency, through the rapid detection of six clinically relevant variants of the DPD enzyme.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction